Skip to content
TrialScanner

NCT04155749

Study of Anitocabtagene-autoleucel in Participants With Relapsed Refractory Multiple Myeloma

Phase 1Active, not recruitingGILDLeadACLXCollaborator

Registry record

Lead sponsor
Kite, A Gilead Company
Conditions
Relapsed and Refractory Multiple Myeloma
Primary completion
Oct 3, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04155749 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04155749: Study of Anitocabtagene-autol... | TrialScanner